Skip to main content
. 2019 Mar 31;52(3):181–189. doi: 10.5483/BMBRep.2019.52.3.048

Fig. 2.

Fig. 2

DUBs involved in the regulation of oncogenic pathways. Inhibition of specific DUBs leads to decreased cancer proliferation, drug resistance, and delayed metastasis.